These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31481418)

  • 41. Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
    Park HS; Lee JD; Kim JY; Park S; Kim JH; Han HJ; Choi YA; Choi AR; Sohn JH; Kim SI
    PLoS One; 2019; 14(12):e0225082. PubMed ID: 31821346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-Derived Xenograft Models of Breast Cancer and Their Application.
    Murayama T; Gotoh N
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics.
    Yan J; Wu X; Yu J; Ma M; Yu H; Xu T; Tang H; Xu L; Dai J; Si L; Chi Z; Sheng X; Cui C; Guo J; Kong Y
    Melanoma Res; 2018 Dec; 28(6):527-535. PubMed ID: 30086074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
    Pan CX; Zhang H; Tepper CG; Lin TY; Davis RR; Keck J; Ghosh PM; Gill P; Airhart S; Bult C; Gandara DR; Liu E; de Vere White RW
    PLoS One; 2015; 10(8):e0134346. PubMed ID: 26270481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer.
    Fong ELS; Toh TB; Lin QXX; Liu Z; Hooi L; Mohd Abdul Rashid MB; Benoukraf T; Chow EK; Huynh TH; Yu H
    Biomaterials; 2018 Mar; 159():229-240. PubMed ID: 29353739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization.
    Dudová Z; Conte N; Mason J; Stuchlík D; Peša R; Halmagyi C; Perova Z; Mosaku A; Thorne R; Follette A; Pivarč Ľ; Šašinka R; Usman M; Neuhauser S; Begley DA; Krupke DM; Frassà M; Fiori A; Corsi R; Vezzadini L; Isella C; Bertotti A; Bult C; Parkinson H; Medico E; Meehan T; Křenek A
    BMC Genomics; 2022 Feb; 23(1):156. PubMed ID: 35193494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review.
    Brown KM; Xue A; Mittal A; Samra JS; Smith R; Hugh TJ
    Oncotarget; 2016 Oct; 7(40):66212-66225. PubMed ID: 27517155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model.
    Mercatali L; La Manna F; Groenewoud A; Casadei R; Recine F; Miserocchi G; Pieri F; Liverani C; Bongiovanni A; Spadazzi C; de Vita A; van der Pluijm G; Giorgini A; Biagini R; Amadori D; Ibrahim T; Snaar-Jagalska E
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?
    Pacheco JM; Byers LA
    Cancer Discov; 2019 Oct; 9(10):1340-1342. PubMed ID: 31575562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
    Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
    Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient-derived xenografts as tools in pharmaceutical development.
    Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
    Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with
    Yao YM; Donoho GP; Iversen PW; Zhang Y; Van Horn RD; Forest A; Novosiadly RD; Webster YW; Ebert P; Bray S; Ting JC; Aggarwal A; Henry JR; Tiu RV; Plowman GD; Peng SB
    Clin Cancer Res; 2017 Sep; 23(18):5547-5560. PubMed ID: 28611205
    [No Abstract]   [Full Text] [Related]  

  • 57. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
    Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
    FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Blomme A; Van Simaeys G; Doumont G; Costanza B; Bellier J; Otaka Y; Sherer F; Lovinfosse P; Boutry S; Palacios AP; De Pauw E; Hirano T; Yokobori T; Hustinx R; Bellahcène A; Delvenne P; Detry O; Goldman S; Nishiyama M; Castronovo V; Turtoi A
    Oncogene; 2018 Mar; 37(9):1237-1250. PubMed ID: 29242606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient-derived xenografts as in vivo models for research in urological malignancies.
    Inoue T; Terada N; Kobayashi T; Ogawa O
    Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.